Compound ID | 3096
Synonym(s): Butyrosin
Class: Aminoglycoside
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor. Binds to 30S ribosomal subunit |
| Target Pathogen: | Active against Staphylococcus aureus, Streptococcus pyogenes, Enterobacter aerogenes, Klebsiella pneumoniae, Pseudomonas aeruginosa, Shigella sonnei, Escherichia coli, and Mycobacterium tuberculosis |
| Description: | Natural product from Bacillus circulans; butirosin resistant strains are cross-resistant to gentamicin (susceptible to colistin); colistin resistant strains not cross-resistant to butirosin; effective against Gram-negative and staphylococcal infection in mice when administered parenterally |
| Institute where first reported: | Parke, Davis & Company, Detroit, Michigan, USA |
| Year first mentioned: | 1972 |
| Highest development stage: | Preliminary human studies (1975) |
| Development status: | Unknown |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/72393 |
| Citations: |
|